Michael C. Dugan - Aug 31, 2021 Form 4 Insider Report for BIOCEPT INC (BIOC)

Role
Chief Med Off & Med. Director
Signature
/s/ Michael W. Nall, Attorney-in-fact
Stock symbol
BIOC
Transactions as of
Aug 31, 2021
Transactions value $
$0
Form type
4
Date filed
9/2/2021, 09:22 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Employee Stock Option (right to buy) Award $0 +150K $0.00 150K Aug 31, 2021 Common Stock 150K $3.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option shall vest monthly following the Vesting Commencement Date of 8/31/21 until fully vested on 8/31/2024.